Strong Year for GWDN Index as Biotech Stocks Rose Sharply in 2012 | GenomeWeb

NEW YORK (GenomeWeb News) – The GenomeWeb Daily News Index, which tracks the stocks of 30 firms that make genomic research tools and molecular diagnostic products, jumped around 18 percent in 2012, as biotech stocks in general enjoyed a strong year.

The GWDN Index bounced back from a difficult 2011, when it fell around 14 percent after a second-half slump.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.